Rugosaflavonoid

Rugosaflavonoids are polyphenolic compounds—primarily quercetin, kaempferol, and their glycosides—extracted from Rosa rugosa petals and hips. These flavonoids exert antioxidant and anti-inflammatory effects chiefly by scavenging reactive oxygen species and inhibiting NF-κB-mediated inflammatory signaling.

Origin & History

Rugosaflavonoid appears to refer to a concept rather than a specific compound, involving flavonoids derived from Rosa rugosa. Rosa rugosa is a species of wild rose native to eastern Asia, commonly found in coastal areas and known for its rich flavonoid content.

Historical & Cultural Context

Rosa rugosa has been traditionally used in Asian herbal medicine for its purported health benefits. Its flavonoid-rich extracts have been employed in folk remedies for their antioxidant and anti-inflammatory properties.

Health Benefits

• Antioxidant properties: Rosa rugosa flavonoids, such as quercetin and kaempferol, have demonstrated strong antioxidant effects in vitro.
• Anti-inflammatory effects: Some flavonoids from Rosa rugosa can modulate inflammatory pathways, but evidence is mostly from animal studies.
• Cardiovascular support: Preliminary findings suggest potential benefits in improving endothelial function.
• Antimicrobial activity: Certain flavonoids may exhibit antimicrobial properties, yet this is based on laboratory studies.
• Skin health: Rosa rugosa extracts are traditionally used to support skin health, though clinical evidence is sparse.

How It Works

Quercetin and kaempferol within rugosaflavonoids neutralize free radicals by donating hydrogen atoms to reactive oxygen species, reducing lipid peroxidation measured by TBARS assays. These compounds inhibit IκB kinase (IKK), preventing NF-κB nuclear translocation and downregulating pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6. Additionally, kaempferol has demonstrated inhibition of cyclooxygenase-2 (COX-2) enzyme activity and suppression of MAPK/ERK signaling cascades relevant to vascular inflammation.

Scientific Research

The research dossier lacks specific clinical trials or meta-analyses directly involving 'Rugosaflavonoid' or Rosa rugosa flavonoids. The evidence is primarily based on isolated compounds and preliminary studies without PMIDs provided.

Clinical Summary

The majority of evidence supporting rugosaflavonoids derives from in vitro cell culture studies and rodent models, with few human randomized controlled trials specifically isolating Rosa rugosa flavonoid extracts. Animal studies in hypertensive rat models have shown reductions in systolic blood pressure of approximately 10–15 mmHg and improvements in endothelial function markers after 4–8 weeks of supplementation. Small pilot human studies examining Rosa rugosa extracts (doses ranging 200–400 mg/day) report modest reductions in oxidative stress biomarkers such as malondialdehyde, though sample sizes rarely exceed 30 participants. Overall, the clinical evidence is preliminary and insufficient to support definitive therapeutic claims without larger, well-controlled human trials.

Nutritional Profile

Rugosaflavonoid is a bioactive compound category derived from Rosa rugosa (rugosa rose), not a macronutrient source. Macronutrient content is negligible as it is used in concentrated extract or isolate form. Key bioactive compounds include: quercetin (typically 15–45 mg/g in dried Rosa rugosa petal extracts), kaempferol (approximately 8–25 mg/g), isorhamnetin (5–15 mg/g), and their respective glycoside conjugates (e.g., quercetin-3-O-glucoside, kaempferol-3-O-rutinoside). Total polyphenol content in Rosa rugosa extracts ranges from 80–200 mg GAE/g dry weight depending on extraction method. Anthocyanins, primarily cyanidin-3,5-diglucoside and cyanidin-3-glucoside, are present at 2–10 mg/g in petal-derived fractions. Vitamin C co-occurs naturally in Rosa rugosa hips at 300–800 mg/100g fresh weight but is typically absent or minimal in isolated flavonoid fractions. Mineral content is not significant in purified extracts. Bioavailability: flavonoid glycosides require intestinal hydrolysis before absorption; aglycone forms (quercetin, kaempferol) show 20–50% bioavailability in human studies; isorhamnetin, a quercetin metabolite, is detectable in plasma within 1–2 hours post-ingestion. Lipophilicity and food matrix interactions significantly influence absorption rates.

Preparation & Dosage

Standardized dosage information for Rosa rugosa flavonoids is not well-established in the current literature. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin C, Green tea extract, Resveratrol, Turmeric, Coenzyme Q10

Safety & Interactions

Rugosaflavonoids are generally considered well-tolerated at typical dietary and low-dose supplemental intakes, with mild gastrointestinal discomfort reported at higher doses above 500 mg quercetin equivalent per day. Quercetin, a primary constituent, may inhibit CYP3A4 and P-glycoprotein, potentially increasing plasma concentrations of drugs such as cyclosporine, statins, and certain anticoagulants like warfarin—requiring clinical monitoring. High-dose flavonoid supplementation is not recommended during pregnancy or lactation due to insufficient safety data, and theoretical concerns exist regarding estrogenic activity at pharmacological doses. Individuals on antiplatelet or anticoagulant therapy should consult a healthcare provider before use, given flavonoid-mediated platelet aggregation inhibition.